Effect of Gutamine Administration in the Innate Immune System Response in ICU Patients.

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

September 30, 2008

Conditions
Moderate to Severe Trauma, as Defined by anInjury Severity Score (ISS) > 12 Points Were Included in the Study.
Interventions
DIETARY_SUPPLEMENT

Total Parenteral Nutrition with Glutamine

daily glutamine supplement of 0.35 g/kg weight as N2-L-Alanyl-L-Glutamine (0.5 g/kg/d - Dipeptiven Fresenius Kabi España) during five days.

OTHER

Total Parenteral Nutrition without glutamine

The control group received a supplemental volume of the basic TPN solution to achieve an isocaloric an isonitrogenated formula with the study group.

Trial Locations (1)

07014

Intensive Care Unit. Hospital Universitario Son Dureta, Palma Mallorca

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Espen

OTHER

collaborator

This research prize was funded by Nestle Nutrition Institute and by Fresenius Kabi.

UNKNOWN

lead

Hospital Universitari Son Dureta

OTHER